DNA Binding to Mouse Cells is Mediated by Cell-Surface Molecules: The Role of These DNA-Binding Molecules as Target Antigens in Murine Lupus

Abstract

Autoimmunity to a 28-29-kDa cell-surface DNA-binding molecule has previously been described in patients with systemic lupus erythematosus and related autoimmune diseases. This report describes experiments that implicate a similar antigen-antibody system in the evolution of autoimmunity in lupus-prone mice. DNA binding to murine spleen cells was found to be a saturable phenomenon that was inhibited by excess cold DNA and trypsinization. The role of autoimmunity to murine cell-surface DNA-binding molecules in lupus-prone mice (MRL lpr/lpr, MRL + / +, BXSB) was compared to normal mice (BALB/c, C3H.SW) by means of an assay that measured the inhibition of cell-surface DNA binding. Only sera from lupus strains had inhibitory activity and this component was shown to be an IgM autoantibody. Furthermore, we isolated a spontaneously occurring IgM monoclonal antibody from the spleen of an MRL/lpr mouse, which inhibited DNA binding to mouse cells. Time-course studies indicated that young female MRL/lpr mice lacked detectable activity against cell- surface DNA-binding molecules; however, by 8-10 weeks maximal inhibitory activity was observed. This response occurred prior to the development of significant antinuclear antibody activity. With the appearance of overt disease and anti-DNA antibodies, inhibition of DNA- binding activity became undetectable. These findings mirror previous studies on autoimmunity to a cell-surface DNA-binding molecule on human leucocytes, but have the added advantage of permitting the study of the temporal evolution of this inhibitory activity in relation to disease expression.

Keywords

Cell-surface DNA-binding molecules Lupus

Get full access to this article

View all access options for this article.

References

Tan EM Autoantibodies to nuclear antigens (ANA): their immunobiology in medicine . Adv Immunol 1982; 33: 167-240.

Okudaira K. , Searles RP , Goodwin JS , Williams RC Antibodies in the sera of patients with SLE that block the binding of monoclonal anti-La to La-positive targets also inhibit the autologous mixed lymphocyte response. J Immunol 1982; 129: 582-6.

Agnello V. The immunopathogenesis of lupus nephritis. Adv Nephrol 1976; 6: 119.

Emlen W. , Pisetsky DS , Taylor RP Antibodies to DNA: a perspective. Arthritis Rheum 1986; 29: 1417-26.

Lies RB , Messner RP , Williams RC Relative T cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum 1973; 16: 362-75.

Morimoto C. , Reinherz EL , Distaso JA Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest 1984; 73: 689-700.

Messner RP , DeHoratius R. , Ferrane S. Lymphocytoxic antibodies in systemic lupus erythematosus patients and their relatives. Reactivity with the HLA antigenic molecular complex. Arthritis Rheum 1980; 23: 265-72.

Moyer MP The association of DNA and RNA with membranes. Int Rev Cytol 1979; 61: 1-61.

Reid BL , Charlson AJ Cytoplasmic and surface deoxyribonucleic acids with consideration to their origin. Int Rev Cytol 1979; 60: 27-52.

10.

Lerner RA , Meinke W. , Goldstein DA Membrane associated DNA in the cytoplasm of diploid human lymphocytes . Proc Natl Acad Sci USA 1971; 68: 1212-6.

11.

Meinke W. , Hall MR , Goldstein DA Physical properties of cytoplasmic membrane associated DNA. J Mol Biol 1973; 78: 43-56.

12.

Meinke W. , Goldstein DA Reassociation and dissociation of cytoplasmic membrane-associated DNA. J Mol Biol 1974; 86: 757-73.

13.

Bennett RM , Davis J. , Merritt MJ Anti-DNA antibodies react with DNA expressed on the surface of monocytes and B lymphocytes. J Rheumatol 1986; 13: 679-85.

14.

Pancer LB , Milazzo MF , Morris VL , Singhal SK , Bell DA Immunogenicity and characterization of supernatant DNA released by murine spleen cells. J Immunol 1981; 127: 98-104.

15.

Distelhorst CW , Cramer K. , Rogers JC Selective release of excreted DNA sequences from phytohemagglutinin-stimulated human peripheral blood lymphocytes. J Clin Invest 1978; 61: 1204-17.

16.

Bennett RM , Gabor GT , Merritt MJ Defective binding to human leukocytes: evidence for a receptor-mediated association, internalization and degradation of DNA. J Clin Invest 1985; 76: 2182-90.

17.

Gabor G. , Bennett RM

Biotin labeled DNA: a novel approach for the recognition of a DNA binding site on cell membranes. Biophys Res

Comm 1984 ; 122: 1034-9.

18.

Bennett RM , Hefeneider SH , Bakke A. et al. The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes. J Immunol 1988; 140: 2937-42.

19.

Emlen W. , Rifai A. , Magilvavy D. , Mannik M. Hepatic binding of DNA is mediated by a receptor on non-parenchymal cells . Am J Pathol 1988; 133: 54-60.

20.

Gasparro FP , DallAmico R. , O'Malley M. , Heald PW , Edelson R. Cell membrane DNA: a new target psoralen photo adduct formation. Photochem Photobiol 1990 ; 52: 315-21.

21.

Loke SL , Stein CA , Zhang XH et al. Characterization of oligonucleotide transport into living cells . Proc Natl Acad Sci USA 1989; 86: 3474-8.

22.

Yakubov LA , Deeva EA , Zarytova VF et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 1989; 86: 6454-8.

23.

Prabhakar BS , Allaway GP , Srinivasappa J. , Notkins AL Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen . J Clin Invest 1990; 86: 1301-5.

24.

Bennett RM , Peller JS , Merritt MJ Defective DNA receptor function in systemic lupus erythematosus and related diseases: evidence for an autoantibody influencing cell physiology . Lancet 1986; i: 186-8.

25.

Bennett RM , Kotzin BC , Merritt MJ DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders: induction of anti-DNA antibodies, anti-histone antibodies and anti-receptor antibodies. J Exp Med 1988; 166: 850-63.

26.

Bennett RM , Langer B. , Molina E. Nucleoprotein-coated latex particles in the serologic diagnosis of systemic lupus erythematosus. Am J Clin Path 1976; 66: 743-5.

27.

Siegle BV , Brown M. , Morton JI Detection of antinuclear antibodies in NZB and other mouse strains . Immunol 1972; 22: 457-63.

28.

Harel-Bellan A. , Ferris DK , Vinocour M. , Holt JT , Farrar WL Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxo-oligonucleotide in human T lymphocytes . J Immunol 1988; 140: 2431-5.

29.

Hefeneider SH , Bennett RM , Pham TQ , Cornell K. , McCoy SL , Heinrich MC Identification of a cell-surface DNA receptor and its association with systemic lupus erythematosus . J Invest Derm 1990; 94S: 79S-84S.

30.

Bennett RM , Cornell KA , Merritt MJ , Bakke AC , Hsu PH , Hefeneider SH Autoimmunity to a 28-30 kilodalton cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and MCTD. Clin Exp Immunol (in press).

31.

Sudar F. , Csaba G. , Robenek H. , Themann H. Localization and internalization of cell surface DNA in macrophages . Cell Mol Biol 1986; 32: 87-91.

32.

Bell DA , Morrison B. , VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 1990; 85: 1487-96.

33.

Rumore PM , Steinman CR Endogenous circulating DNA in systemic lupus erythematosus. J Clin Invest 1990; 86: 69-74.

34.

Hefeneider SH , Siegle JM , Brown LE , Cornell KA , McCoy SL , Bennett RM Cytokine production by cells exposed to DNA and MAB's to the DNA receptor. Arthritis Rheum 1991; 34: R15 (abstract).